Alnylam Pharmace. buy daimler1
Start price
26.02.23
/
50%
€182.32
Target price
26.02.24
-
Performance (%)
2.35%
End price
02.04.23
€186.60
Summary
This prediction ended on 02.04.23 with a price of €186.60. The BUY prediction by daimler1 finished with a performance of 2.35%. daimler1 has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Alnylam Pharmace. | -4.258% | -4.258% | 27.595% | 39.650% |
| iShares Core DAX® | 3,59 % | 3,93 % | 15,38 % | 53,20 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % | 41,46 % | 91,09 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % | 48,95 % | 63,93 % |
| iShares S&P 500 | 4,14 % | 4,04 % | 31,59 % | 64,84 % |
Comments by daimler1 for this prediction
In the thread Alnylam Pharmace. diskutieren
Buy Alnylam Pharmace.